Mitochondria as targets for cancer therapy

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652036%3A_____%2F09%3A00340634" target="_blank" >RIV/86652036:_____/09:00340634 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Mitochondria as targets for cancer therapy

Original language description

Many recent literature findings illustrate the fact that a variety of compounds active in cancer cells act via mitochondria. These compounds, termed mitocans, destabilise mitochondria and cause apoptosis, which is, at least in some cases, selective for cancer cells. Thus, novel drugs offer substantial promise as potent and effective clinical treatments with minimal side-effects. The chapter on mitochondria as targets for cancer therapy is included in the book presenting thorough analyses of mitochondrial dysfunction as one of the hallmarks of cancer and discussing the clinical implications of cancer mitochondrial defects

Czech name

—

Czech description

—

Type

C - Chapter in a specialist book

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2009

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Book/collection name

Mitochondria and Cancer

ISBN

978-0-387-84834-1

Number of pages of the result

39

Pages from-to

—

Number of pages of the book

291

Publisher name

Springer Science + Business Media

Place of publication

New York

UT code for WoS chapter

—